Excessive portal venous supply of long-chain free fatty acids to the liver, leading to hypothalamus-pituitary-adrenal-axis and sympathetic activation as a key to the development of Syndrome X -A proposed concept for the induction of Syndrome X
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Insulin resistance and hypertension are two major symptoms of Syndrome X. A distinct relation between these symptoms and weight maintenance has been observed. Weight gain decreases insulin sensitivity and glucose tolerance and increases blood pressure, while loss of excessive weight normalizes these symptoms.
1,2 Epidemiological studies show that upper-body obesity is associated with a higher incidence of the symptoms of Syndrome X than is lower-body obesity. 3, 4 This is primarily related to the amount of visceral fat rather than to the amount of subcutaneous fat. 3, 5 The causal relationship between visceral obesity and Syndrome X, however, is still unknown.
A clue to this relation may be found in the metabolic characteristics and anatomical location of visceral adipose tissue. Visceral adipose tissue, especially the omental and mesenteric fat pads, which are drained by the portal circulation, has metabolic characteristics that are unique in comparison with other adipose tissues. The fat cells from these regions are metabolically more active, 6 they have increased ␤ 3 -adrenoceptor sensitivity, 7 and they have a higher lipolytic activity 5 than do other adipocytes. Moreover, the inhibitory action of insulin on fatty acid release from visceral adipocytes is lower than in subcutaneous fat cells. 8 It has subsequently been demonstrated that visceral obesity is associated with increased fatty acid release and turnover 9 and with an elevated fasting plasma fatty acid concentration. 10 Normally, the liver will not be exposed to an exuberant supply of long-chain fatty acids, because long-chain fatty acids absorbed from the gut are mainly transported as triglycerides incorporated in chylomicrons by the lymphatic system, thus bypassing the liver. Primary metabolism of chylomicrons takes place in fat and muscle; the chylomicron remnants are subsequently taken up and metabolized by the liver. The increased lipolytic rate in visceral adipocytes in upper-body obesity and the direct drainage to the portal vein create a situation in which the liver directly will be ex-posed to an exaggerated supply of long-chain fatty acids, long-chain fatty acids being the most prevalent product of lipolysis. Moreover, this high exposure may be confined to specific peripheral hepatocyte populations that may differ from those that usually take up plasma lipoproteins and secrete VLDL.
11
Increased hepatic supply of long-chain fatty acids may have adverse effects on hepatic function. In obese patients, increased serum transaminase activities, indicators of hepatic malfunction, have been documented. 12 A strong correlation between waisthip ratio and plasma transaminase concentrations and characteristics of the metabolic syndrome has been reported. 13 Fagerberg et al. 14 reported a significant correlation of alanine aminotransferase to plasma insulin, independent of body mass index. Moreover, Perry et al. 15 found a strong, graded, and independent association between the concentration of ␥-glutamyltransferase in serum and the risk of Type 2 diabetes FIGURE 1. Hypothesized concept for the induction of Syndrome X. Excessive portal venous supply of long-chain fatty acids to the liver induces changes in hepatic function as indicated by increased plasma concentrations of aminotransferases (ALT, alanine aminotransferase). This process induces increased afferent neural activity from the liver, or humoral sensing by the central nervous system (CNS), leading to reflex sympatho-adrenal (symp) and hypothalamus-pituitary-adrenal-axis (HPA-axis) activity. This increased sympatho-adrenal and HPA-axis activity can lead to the development of insulin resistance (ins resist) and consequently hyperinsulinemia (hyperins), ultimately leading to Type 2 diabetes. Besides, increased sympatho-adrenal and HPA-axis activity can lead to, among others, vasoconstriction and increased Na + -retention, factors that ultimately can lead to hypertension. The induction of insulin resistance on the one hand, and the stimulation of ␤ 3 -adrenoreceptors on visceral fat pads (visc ␤3-adr) by norepinephrine from sympathetic neurons on the other hand, can lead to increased fatty acid levels, maintaining the hypothesized system. during long-term follow-up. Based on these observations, we propose that changes in hepatic function, possibly related to excessive supply of long-chain fatty acids to the liver, could play an important role in the development of Syndrome X. These changes in hepatic function are hypothesized to induce afferent neural activity from the liver, resulting in a reflex increase in the sympatho-adrenal and hypothalamus-pituitaryadrenal-axis (HPA-axis) activity (see FIG. 1 for an outline) . In obesity, increased HPA-axis activity and sympathetic activity are commonly observed and are associated with hypertension and insulin resistance. [16] [17] [18] Grekin and co-workers 19, 20 provided evidence for reflex activation of the sympatho-adrenal system and HPA-axis in rats by increased supply of long-chain, but not medium-chain, fatty acids to the liver. This activation was associated with an increase in heart rate and blood pressure. We recently investigated whether increased HPAaxis activity and sympathetic activity induced by an increased portal venous supply of long-chain fatty acids to the liver could initiate the development of insulin resistance. We found that continuous intraportal infusion of oleate (150 nmol/min) for 24 h in rats led to increases in activity of the HPA-axis and sympathetic system, while infusion of caprylate at the same rate did not. 21 In the oleate-infused animals we observed a more than twofold increased insulin response to an intravenous glucose tolerance test, when compared to the control groups, whereas the glucose response was not affected. This clearly indicates that insulin resistance develops within 24 h of portal venous oleate infusion.
Based upon the results presented by Grekin et al. 19, 20 and our own results, it is our working hypothesis that excessive long-chain fatty acid supply to the liver induces changes in hepatic function that lead to reflex activation of the HPA-axis and sympathetic system. We hypothesize this concept to be central in the induction of visceral obesity-related hypertension and insulin resistance ( see FIG. 1 ). It may be the "common soil" referred to in the perspective of the development of Syndrome X. 22 
